chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st dose in 2021, has not received dose 2; This case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 12th July 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 14-Nov-2022 Reporter's comment: The patient has not yet received dose 2 of Shingrix. No birth date or age available at time of call and no further details were provided.  The reporter consented to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete curse of vaccination.
Patient starting complaining of itchiness to entire body, given diphenhydramine HCL 25mg 1 tab PO at 2:00pm, checked vital signs when medication was administered and after 15 minutes stayed within normal limits, symptoms resolved within 20 minutes after medication administration, no other symptoms.
pt recvd vax; 4 hrs later c/o a sore arm;had an uncontrolable crying spell,lasting >2 hrs;had n, v x2; fatigue, drowsiness; consulted MD; tx w/ apap for T 103po; resolved by 6feb95;
Pt transferred from outlying ED due to NSTEMI and AKI and also found to be COVID positive.
Patient experienced a brief syncopal episode several minutes after vaccine admin.  Pt was hypotensive for approx 20 min post vaccination.  Released to family, self transport to ER.  Medic for PCR
Tuesday he started with a fever and vomiting. 101 or 102 for the highest fever. That was all night long. Next day fever was 101, a little vomiting and that stopped. Since then, It's been 99.8. up to 101. Yesterday it got to 100 but it was starting to get lower during the night. Never got up past 99.4. better and lower today and hasn't gotten as sick as the 1st day. Stomach hurts at times. He was more tired but that was to be expected. He seems okay today.
Pain and stiffness in arm around injection site, starting a few hours after injection. Stiffness in back, legs, arms (increasing at injection site), pain in calves apx 12 hours after injection. Fever starting apx 20 hours after injection. Restlessness, insomnia (mostly from feeling so uncomfortable) general listlessness, nausea starting this morning (Sunday) productive cough (clear white mucus).
Immediately after getting vaccine pt became light headed and nauseous, symptoms did not resolve after lying flat for several minutes.  Pt BP was initially 87/52 lying down then 88/52 sitting up.  Secondary to hypotension, GI symptoms and lightheadedness pt was treated with Epi Pen.  Symptoms immediately resolved, BP returned to normal and pt was observed for 30 minutes prior to sending pt home.
Pt had Px exam 11-25-08.  GARDASIL #1, MENACTRA & ADACEL given to update imms-  Pt has since learned that she was pregnant at time of vaccine administration (2 weeks pregnant), unaware of any adverse reaction
Chills; Body aches; Fever; Headache; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received a second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3248) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks of vaccination. The patient did not receive any other medications within 2 weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6203) via an unspecified route of administration in the left arm on 03Mar2021 at 11:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. On 26Mar2021, 12 hours after vaccination the patient experienced chills, body aches, fever and headache (felt like a sinus headache) that lasted all evening into the following day and all events subsided approximately 24 hours later. The patient did not receive any treatment for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and the emergency room/department or urgent care. The clinical outcome of the events chills, body aches, fever and headache were recovered on 27Mar2021 after the duration of 24 hrs.   No follow-up attempts are needed. No further information is expected.
Mild swelling on the evening of vaccine administration. Swelling much more pronounced the next morning and continues to increase. Other symptoms: warmth, tenderness, fever (was 102.6 F on 9/19) Pt. seen 9/20, had swelling of left arm starting below punctum and contimuing below elbow. Covers entire outer aspect of arm. Treatment included Tylenol, ibuprofen, Benadryl, cool compresses. Started Prednisone taper today.
Severely swollen and Severely painful lymph node and gland left side where Trigeminal Neuralgia and Glossopharyngeal Neuralgia and Tinnitus are too. Required a Biopsy too!
Pt stated she could not swallow as well as she normally does. Pt did not complain of SOB.
they even bruised my nerves in my arm,  it doesn't hurts on the surface its deep inside; they even bruised my nerves in my arm,  it doesn't hurts on the surface its deep inside; I am limited with what I can do with arm because of the pain.; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported, Expiry date: unknown), dose 2 via an unspecified route of administration on 21Apr2021 as dose2, single for covid-19 immunisation. The patient medical history and concomitant medications was not reported. Historical vaccine of BNT162B2 for Covid-19 Immunization as first dose. The patient experienced they even bruised my nerves in my arm, it doesn't hurts on the surface its deep inside, i am limited with what i can do with arm because of the pain on an unspecified date. Patient stated, I had the Pfizer shot alright, the second shot of the Pfizer was on 21Apr this year ok, that's second shot my arm is still hurting ever since then. Patient got the shot at the VA clinic ok, patient kept call him back telling that am having pain in my arm with the shot with in. They tell me all, go way 2 more weeks back call him, okay. Patient talked several time with them, they are telling me, all we give you therapy, patient stated something is wrong with my arm, they even bruised my nerves in my arm, it doesn't hurts on the surface its deep inside and patient was limited with what patient can do with arm because of the pain. Patient want to know what the problem is. Patient called out to where the university office they said they doesn't see how any kind of therapy its gonna help what am telling with my arm, there are 4 different agencies and patient get around every time, something is wrong. Consumer was informed about medical information department. As consumer hung up the call abruptly. Hence further probing could not be done. Limited information available over the call. The outcome of events was unknown.  Information regarding the Lot/Batch number has been requested.
Expired vaccine used/ no adverse event; Initial information regarding an unsolicited valid non-serious case was received from other health care professional via Medical Information Reference number- 00388271) and transmitted to Sanofi on 10-Deca-2020.   This case involves 1 year patient who received an expired dose of HAEMOPHILUS TYPE B (HIB) VACCINE (ACT-HIB) (lot number powder: UJ161AA  02-MAY-2021;  diluent no lot number available, expired 26-NOV-2020) via an intramuscular route in an left leg for prophylactic vaccination, on an 26-Nov-2020 (expired product administered).   The patient's medical history, past medical treatment(s), vaccination(s), concomitant medications and family history were not provided.   This was an actual medication error case due to expired diluent was used when preparing ActHIB.  (latency same day).   At the time of reporting, no adverse event was reported.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holders compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
PATEINT REPORTED HAVING FEVER, RASH ON FACE, CHEST, AND ABDOMEN AREA. ITCHING, HEADACHE. AFTER THE SECOND DAY WITH THE SYMPTOMS, RECEIVE TREATMENT IN HOSPITAL, ZYRTEC 10 MG 1 TAB DAILY. SHE RECOVERED 3 DAYS LATER.
clear chest xray sept 22, chest xray on 01-13-23 shows MASSIVE Lymphoma, hospitalized, cant eat, 2nd biopsy today
Very tired; Real Achy; Bones hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Real Achy), BONE PAIN (Bones hurt) and FATIGUE (Very tired) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (Medical history reported as COVID) in August 2020.    On 11-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced PAIN (Real Achy) and BONE PAIN (Bones hurt). On 13-Jan-2021, the patient experienced FATIGUE (Very tired). On 13-Jan-2021, PAIN (Real Achy), BONE PAIN (Bones hurt) and FATIGUE (Very tired) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment for the events included paracetamol.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
On the night of the second injection (7/9/2021) I began to experience moderate joint pain.  The following morning (7/10/2021) I took 400 mg ibuprofen and the pain subsided and has not returned. On the third day post injection (7-11-2021) I developed a herpes simplex sore on my upper lip and have taken 6 doses of 400 mg of acyclovir, the sore is slowly healing. On the fourth day post injection (7/12/2021) I developed allergy symptoms: itchy eyes, nose, ears, scalp, runny nose, drier facial skin.  I have taken two doses of OTC Zyrtec and none of the symptoms have lessened and are ongoing (7/13/2021).  Also, the skin between and under my breasts and my right thumb peeled off like a sunburn had occurred, but the skin had not been exposed to any sunlight.  No more signs of this symptom at this time. (7/13/2021).
pt recv vax & devel itching all over body; MD prescribed DPH, which mom said did not help the itching; just made the pt sleepy; also developed hair loss several wk p/vax which cont; MD has ordered blood work;
He is newly hypertensive with blood pressure 160/72 with continued cold sweats/"blah" feelings for the month since his second covid vaccine. Suspect he's having symptomatic hypertension. BP has never been uncontrolled recently and he was last seen 3/21
Weakness; Muscle aches; This case was reported by a consumer via call center representative and described the occurrence of weakness in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced weakness and muscle pain. On an unknown date, the outcome of the weakness and muscle pain were not recovered/not resolved.   It was unknown if the reporter considered the weakness and muscle pain to be related to Shingrix.  Additional information was provided as follows: The age at vaccination was not reported. The patient wanted to know how long did side effects last like weakness and muscle aches.
zoster related rash; Information has been received from a lawyer regarding a case in litigation and refers to a patient (pt) of an unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 15-OCT-2012, the pt was inoculated with zoster vaccine live (ZOSTAVAX) (strength, dose, dose number, route, anatomical site of vaccination, lot number and expiration date were not provided) as prescribed and/or administered by a pharmacist for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date (reported as subsequent to pt's zoster vaccine live (ZOSTAVAX) inoculation), the pt was treated by a healthcare provider at a hospital for zoster related rash (herpes zoster). On an unknown date, the pt was admitted to the hospital due to the event. As a direct and proximate result of pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, the pt had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and would continue to suffer such losses, and damages in the future. At the time of this report, the outcome of herpes zoster was unknown. The lawyer considered the event to be related to zoster vaccine live (ZOSTAVAX).
pt recv vax 8APR96 & 21JUN96 revealed that pt was non immune;no further details were provided;
Malaise, fever for 2 weeks after vaccination, resolved, then had HA, stiff neck, decreased mentation beginning 25 days after vaccination.   Per documents from CDC: Pt developed flu-like sx including fever, myalgias and H/A 2 days s/p vax.  These sx resolved over the following 2 weeks.  On 9/29/2007 (20 days s/p vax) pt developed  acute onset of nausea and H/A.  Sx worsened and pt developed confusion.  Pt admitted to local hospital with fever and confusion.  During admission mental status continued to decline and pt became unresponsive. Txd with abx, antivirals, and eventually corticosteroids from which pt had a good response, but not return to baseline mental status.  Transfered to another facility for further eval and tx.  11/5/2007 MR received from transfer facility for DOS 10/08-16/2007 with D/C DX: Meningoencephalitis. Chronic Lymphocytic Leukemia. Pt presented as above. Per D/c Summary "it is most likely that pt did have yellow fever reactivation meningoencephalitis". No evidence of encephalitis upon d/c.
Experienced very high fever for 4 to 6 hours, subsided, then returned a couple hours later, but not as high Joint pain for two days
Post vax pt started vomiting with a fever on 5/8/2000. Treatment with Tylenol for fever and clear liquids in small amounts until tolerated. Pt not any better MD noted lesions noted on pharynx, palate, and throat. Lesions also with edema noted on penis and scrotum, instructions were to give pedialyte and Tylenol every 4 hours or Motrin every six hours until vomiting and fever are gone.
Fever after second dose; Chills after second dose; Whole body hurt after the second; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever after second dose), CHILLS (Chills after second dose) and MYALGIA (Whole body hurt after the second) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever after second dose), CHILLS (Chills after second dose) and MYALGIA (Whole body hurt after the second). At the time of the report, PYREXIA (Fever after second dose), CHILLS (Chills after second dose) and MYALGIA (Whole body hurt after the second) outcome was unknown.            No Concomitants and Treatment medication were reported.
This spontaneous report as received from a consumer refers to an unspecified number of patients of unknown age. On an unknown date, patients were vaccinated with a dose of (Oka/Merck) VARIVAX (lot #, expiration date, dose, route, indication not reported) that had arrived "without dry ice", indicated that the vaccine might have gone through an excursion. The reporter did not specify the exact temperature of the shipment. No adverse experience reported. Additional information is not expected due to the reporter did not wish to provide any information.
2min p/vax felt like was smothering, heat in face, then descended down rt side turning into rt low back pain; felt like legs were paralyzed; no LOC, resp, or cardiac abnormalities; when lifted onto gurney, felt "pop" in back & sx resolved;
I had a trigger of Lyme symptoms, brain fog, memory loss, burning sensation in my legs, brain stem, depression, fatigue could not follow complex thinking.
red, itchy swelling on her arm at the injection site; red, itchy swelling on her arm at the injection site; red, itchy swelling on her arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (red, itchy swelling on her arm at the injection site), VACCINATION SITE ERYTHEMA (red, itchy swelling on her arm at the injection site) and VACCINATION SITE SWELLING (red, itchy swelling on her arm at the injection site) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (red, itchy swelling on her arm at the injection site), VACCINATION SITE ERYTHEMA (red, itchy swelling on her arm at the injection site) and VACCINATION SITE SWELLING (red, itchy swelling on her arm at the injection site). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (red, itchy swelling on her arm at the injection site), VACCINATION SITE ERYTHEMA (red, itchy swelling on her arm at the injection site) and VACCINATION SITE SWELLING (red, itchy swelling on her arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.
Onset on dental hypersensitivity within 24 hrs injection. Dental pain lasted 3 months. No known changes in oral hygiene or identified dental issues confounding pain. Patient describes pain as, "cold air on teeth pain."
Significant baseball sized swelling in lymph node under right armpit.  (Vaccinated arm).
Pt recvd rubella vax 13FEB91 & on 27FEB91 pt exp pruritic maculopapular rash on face, trunk & arms; MD felt that "it was compatible w/German measles rash; By 04MAR91 pt had recoverd;
Body aches, fever-, sinus congestion, nasal congestion, cough, headache, and ear pain, starting on 11/13/21.
excruciating pain all over the body and headache which started after covid vaccine on 3/8 Pfizer. Symptoms started 3/12.   Stopped the crestor and only the leg cramps stopped. Tylenol and baclofen did not help. Went to ER for pain and was given IV dilaudid and toradol which helped at the time. She was rx norco. She tried 2 tabs at a time and threw up. She is just takin g1 tab q4 hrs now which helps with the body aches but not the headache.
Expired Vaccine administered to 18 patients; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered to 18 patients) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 034C21A) for COVID-19 vaccination.     patient information was not reported patient medical history information was not reported.     In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine administered to 18 patients).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medication was reported. No treatment medication was reported. Moderna cannot guarantee patients received full protection against the COVID-19 Virus   Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Non Significant Followup - Patient Reported No Adverse Event. On 28-Jul-2021: Follow Up Information received on 28 Jul 2021, contains NNI
Numbness and tingling in arm; Metallic taste; Tingling around mouth; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (Numbness and tingling in arm), DYSGEUSIA (Metallic taste) and PARAESTHESIA ORAL (Tingling around mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jan-2021, the patient experienced PARAESTHESIA (Numbness and tingling in arm), DYSGEUSIA (Metallic taste) and PARAESTHESIA ORAL (Tingling around mouth). On 07-Jan-2021, PARAESTHESIA (Numbness and tingling in arm), DYSGEUSIA (Metallic taste) and PARAESTHESIA ORAL (Tingling around mouth) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Large localized itchy, mildly painful, erythematous area to site of 2 concurrent vaccines.